(Q43889366)

27 November 2017

title

The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders (English)

1 reference

27 November 2017

1 reference

1 reference

venous thromboembolism

1 reference

Johan R Meinardi

1

1 reference

27 November 2017

Saskia Middeldorp

2

1 reference

27 November 2017

Pieter J de Kam

3

1 reference

27 November 2017

Maria M W Koopman

4

1 reference

27 November 2017

Elisabeth C M van Pampus

5

1 reference

27 November 2017

Karly Hamulyák

6

1 reference

27 November 2017

Martin H Prins

7

1 reference

27 November 2017

Harry R Büller

8

1 reference

27 November 2017

Jan van der Meer

9

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

British Journal of Haematology

27 November 2017

published in

1 reference

27 November 2017

volume

116

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

625-631

1 reference

Mutation in blood coagulation factor V associated with resistance to activated protein C.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03303.X

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03303.X

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03303.X

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03303.X

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03303.X

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03303.X

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03303.X

10.1046/J.0007-1048.2001.03303.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference